Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$35.68 - $44.71 $8,491 - $10,640
-238 Reduced 2.8%
8,252 $340,000
Q4 2021

Feb 14, 2022

SELL
$47.19 - $62.68 $93,011 - $123,542
-1,971 Reduced 18.84%
8,490 $446,000
Q3 2021

Nov 12, 2021

SELL
$56.91 - $67.81 $17,243 - $20,546
-303 Reduced 2.81%
10,461 $626,000
Q1 2021

May 13, 2021

SELL
$53.26 - $68.08 $80,582 - $103,005
-1,513 Reduced 12.32%
10,764 $706,000
Q4 2020

Feb 09, 2021

SELL
$43.41 - $56.51 $89,250 - $116,184
-2,056 Reduced 14.34%
12,277 $692,000
Q2 2020

Aug 12, 2020

BUY
$43.51 - $66.59 $5,003 - $7,657
115 Added 0.81%
14,333 $798,000
Q1 2020

May 11, 2020

SELL
$32.82 - $81.13 $151,890 - $375,469
-4,628 Reduced 24.56%
14,218 $720,000
Q4 2019

Feb 13, 2020

BUY
$60.96 - $77.7 $209,336 - $266,821
3,434 Added 22.28%
18,846 $1.46 Million
Q3 2019

Nov 12, 2019

SELL
$55.78 - $68.08 $55,556 - $67,807
-996 Reduced 6.07%
15,412 $977,000
Q2 2019

Aug 13, 2019

SELL
$53.69 - $65.47 $165,955 - $202,367
-3,091 Reduced 15.85%
16,408 $961,000
Q1 2019

May 14, 2019

SELL
$44.53 - $58.9 $7,570 - $10,013
-170 Reduced 0.86%
19,499 $1.11 Million
Q4 2018

Feb 14, 2019

SELL
$47.64 - $71.26 $28,584 - $42,756
-600 Reduced 2.96%
19,669 $975,000
Q3 2018

Nov 13, 2018

SELL
$52.03 - $71.41 $88,711 - $121,754
-1,705 Reduced 7.76%
20,269 $1.44 Million
Q2 2018

Aug 13, 2018

SELL
$48.15 - $56.68 $669,092 - $787,625
-13,896 Reduced 38.74%
21,974 $1.15 Million
Q1 2018

May 15, 2018

SELL
$46.03 - $61.28 $111,668 - $148,665
-2,426 Reduced 6.33%
35,870 $1.87 Million
Q4 2017

Feb 14, 2018

SELL
$50.58 - $60.79 $15.2 Million - $18.3 Million
-301,469 Reduced 88.73%
38,296 $2.24 Million
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $18.2 Million - $23.1 Million
339,765
339,765 $18.8 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.